Zhi Hong Chen
Director/Board Member at Shanghai Neutan Pharmaceutical Co., Ltd.
Zhi Hong Chen active positions
| Companies | Position | Start | End |
|---|---|---|---|
Shanghai Neutan Pharmaceutical Co., Ltd.
 Shanghai Neutan Pharmaceutical Co., Ltd. BiotechnologyHealth Technology Shanghai Neutan Pharmaceutical Co., Ltd. provides synthetic chemistry and customization services. Shanghai Neutan Pharmaceutical Co. is a national high-tech enterprise and a one-stop full-process innovative drug CDMO platform. The company is based in Shanghai, China. The Chinese company has established a complete quality assurance system that complies with domestic and international GMP standards. The company offers high-quality CMC, clinical samples, and commercial products. The company's business scope includes pre-clinical CRO, new drug discovery FTE, CMC, new drug discovery FFS, CXO, etc. The company was founded in 2019 by Xue Jun Liu, and the CEO is Xiao Dong Chen. | Director/Board Member | - | - |
Career history of Zhi Hong Chen
Former positions of Zhi Hong Chen
| Companies | Position | Start | End |
|---|---|---|---|
| ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD | Director/Board Member | - | - |
| Chief Executive Officer | - | - |
Statistics
International
| China | 3 |
Operational
| Director/Board Member | 2 |
| Chief Executive Officer | 1 |
Sectoral
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD | Health Technology |
| Private companies | 1 |
|---|---|
Shanghai Neutan Pharmaceutical Co., Ltd.
Shanghai Neutan Pharmaceutical Co., Ltd. BiotechnologyHealth Technology Shanghai Neutan Pharmaceutical Co., Ltd. provides synthetic chemistry and customization services. Shanghai Neutan Pharmaceutical Co. is a national high-tech enterprise and a one-stop full-process innovative drug CDMO platform. The company is based in Shanghai, China. The Chinese company has established a complete quality assurance system that complies with domestic and international GMP standards. The company offers high-quality CMC, clinical samples, and commercial products. The company's business scope includes pre-clinical CRO, new drug discovery FTE, CMC, new drug discovery FFS, CXO, etc. The company was founded in 2019 by Xue Jun Liu, and the CEO is Xiao Dong Chen. | Health Technology |
- Stock Market
- Insiders
- Zhi Hong Chen
- Experience
